DTIL
PRECISION BIOSCIENCES INC
NASDAQ · Healthcare · Biotechnology · US
$6.67
+0.00%Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- -$0.85
- Revenue estimate
- $1.4M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$1.26
- EPS estimate
- -$0.80
- Revenue actual
- —
- Revenue estimate
- $740.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -690.8%
- Revenue beats (12Q)
- 4
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.80 | -$1.26 | Miss -56.72% | — |
| May 5, 2026 | -$0.27 | -$0.34 | Miss -25.93% | $10.8M |
| Aug 7, 2025 | -$0.09 | -$2.13 | Miss -2266.67% | — |
| May 15, 2025 | -$0.43 | -$2.21 | Miss -413.95% | — |
| Mar 26, 2025 | -$2.09 | -$3.20 | Miss -53.11% | $638.0K |
| Aug 1, 2024 | -$0.77 | $3.46 | Beat 549.35% | $49.9M |
| Aug 4, 2023 | -$6.91 | -$3.00 | Beat 56.58% | $19.8M |
| Mar 9, 2023 | -$7.21 | -$7.81 | Miss -8.32% | $10.6M |
| Mar 15, 2022 | -$14 | -$11 | Beat 20.82% | $6.3M |
| Nov 10, 2021 | -$18 | -$5.71 | Beat 68.31% | $24.0M |
| Aug 12, 2021 | -$11 | $11 | Beat 194.74% | $68.8M |
| May 13, 2021 | -$15 | -$9.91 | Beat 32.63% | $16.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026